PharmaShots | Incisive News in 3 Shots

Subscribe Now

anemia

GSK Presents Results of Daprodustat in P-III ASCEND Program for the Treatment of Anemia due to Chronic Kidney Disease at ASN Kidney Week 2021

GSK Presents Results of Daprodustat in P-III ASCEND Program for the Treatment of Anemia due to Chronic Kidney Disease at ASN Kidne...

November 8, 2021

The US FDA's Rejects FibroGen's Roxadustat for the Treatment of Anemia Due to CKD

The US FDA's Rejects FibroGen's Roxadustat for the Treatment of Anemia Due to CKD

August 11, 2021

Akebia Presents Results of Vadadustat in P-lll INNO2VATE Program for Anemia Due to CKD at ASN Kidney Week

Akebia Presents Results of Vadadustat in P-lll INNO2VATE Program for Anemia Due to CKD at ASN Kidney Week

October 23, 2020

Astellas Reports Results of Roxadustat in P-III DOLOMITES Study to Treat Anemia in Non-Dialysis Dependent Adult Patients with Chronic Kidney Disease

Astellas Reports Results of Roxadustat in P-III DOLOMITES Study to Treat Anemia in Non-Dialysis Dependent Adult Patients with Chro...

June 9, 2020

Astellas Reports Submission of sNDA to MHLW for Evrenzo (roxadustat) to Treat Anemia Associated with Chronic Kidney Disease in Non-Dialysis Dependent Patients in Japan

Astellas Reports Submission of sNDA to MHLW for Evrenzo (roxadustat) to Treat Anemia Associated with Chronic Kidney Disease in Non...

January 30, 2020

PharmaShots Interview: AstraZeneca's Global Medicine Leader John Houghton Shares Insights on Roxadustat in Treating Patients with Anemia Due to CKD at ASN 2019

PharmaShots Interview: AstraZeneca's Global Medicine Leader John Houghton Shares Insights on Roxadustat in Treating Patients with...

November 12, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us